Overview

A Study To Estimate The Effects Of Itraconazole On Pharmacokinetics Of Pf-06649751 In Healthy Adult Subjects

Status:
Completed
Trial end date:
2017-09-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the impact of CYP3A4 inhibitor, itraconazole, on plasma concentration of PF-06649751 in healthy subjects
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Hydroxyitraconazole
Itraconazole